Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries:: Prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours

被引:21
作者
Gyoengyoesi, Mariann
Strehblow, Christoph
Sperker, Wolfgang
Hevesi, Akos
Garamvolgyi, Rita
Petrasi, Zsolt
Pavo, Noemi
Ferdinandy, Peter
Csonka, Csaba
Csont, Tamas
Sylvn, Christer
Declerck, Paul J.
Pavo, Irnre
Wojta, Johann
Glogar, Dietmar
Huber, Kurt
机构
[1] Med Univ Vienna, Dept Cardiol, A-1090 Vienna, Austria
[2] Univ Kaposvar, Inst Diagnost Imaging & Radiat Oncol, Kaposvar, Hungary
[3] Univ Szeged, Dept Biochem, Cardiovasc Res Grp, Szeged, Hungary
[4] Karolinska Univ Hosp, Karolinska Inst, Dept Cardiol, Stockholm, Sweden
[5] Katholieke Univ Leuven, Fac Pharmaceut Sci, Lab Pharmaceut Biol & Phytopharmacol, Louvain, Belgium
[6] Wilhelminenhosp, Dept Med Cardiol & Emergency Med 3, Vienna, Austria
关键词
platelets; stents; thrombosis; coronary circulation; tissue factor; FACTOR EXPRESSION; PORCINE MODEL; P-SELECTIN; ABCIXIMAB; INTERVENTION; ANGIOPLASTY; RESTENOSIS; RISK; COAGULATION; OCCLUSION;
D O I
10.1160/TH06-03-0178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increased thrombogenicity of drug-eluting stents (DESs) has recently been reported. The aim of the present study was to investigate the prothrombogenic effect of DESs and Bare stents, and determine factors predictive of acute stent thrombosis (AST) in preclinical experiments using new stent design or coating. Circulating pre- and post-stenting parameters of platelet activation (mean platelet volume, MPV; platelet distribution width, platelet large cell ratio), thrombin activation (thrombin-antithrombin complex,TAT and prothrombin fragments, F1+2), tissue factor antigen (TF-ag) and -activity (TF-act) and plasminogen activator inhibitor-1 (PAI-1) were measured in 141 consecutive pigs. Stent implantations were performed after pretreatment with aspirin and clopidogrel with unfractionated heparin anticoagulation. Nineteen pigs (groups AST-DES, n = 12; and AST-Bare, n = 7) died mean 6.3 +/- 2.9 h after stent implantation from AST. The remaining 122 control (C) pigs (groups C-DES, n = 76, and C-Bare, n = 46) survived the 1-month follow-up. Non-significantly elevated levels of post-stent F1+2 and TAT were measured in AST groups. Post-stenting MPV was increased significantly in the groups AST-DES and AST-Bare as compared with the groups C-DES and C-Bare (11.73 +/- 1.12 and 11.6 +/- 0.68 vs. 8.85 +/- 0.78 and 9.04 +/- 0.81 fL; p < 0.001), similarly to TF-ag (189.1 +/- 87.5 and 127 +/- 34.9 vs. 42.5 +/- 24.6 and 35.3 +/- 37.6 pg/ml; p < 0.001, respectively), TF-act (3.23 +/- 0.95 and 2.73 +/- 1.68 vs. 1.43 +/- 1.12 and 1.61 +/- 1.31 pM; p < 0.01, respectively) and PAI-1 (99.1 +/- 15.8 and 99 +/- 14.7 vs. 53.4 +/- 40.2 and 46.9 +/- 42.4 ng/ml; p < 0.01, respectively). Multivariate analysis revealed elevated post-stenting plasma levels of TF-ag (p = 0.016) and MPV (p = 0.001) as independent risk factors for developing AST within the first 24 h in a porcine coronary stent model.
引用
收藏
页码:202 / 209
页数:8
相关论文
共 42 条
[1]   Findings of intravascular ultrasound during acute stent thrombosis [J].
Alfonso, F ;
Suárez, A ;
Angiolillo, DJ ;
Sabaté, M ;
Escaned, J ;
Moreno, R ;
Hernández, R ;
Bañuelos, C ;
Macaya, C .
HEART, 2004, 90 (12) :1455-1459
[2]   What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis [J].
Bavry, AA ;
Kumbhani, DJ ;
Helton, TJ ;
Bhatt, DL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (06) :941-946
[3]   Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era [J].
Biondi-Zoccai, GGL ;
Sangiorgi, GM ;
Chieffo, A ;
Vittori, G ;
Falchetti, E ;
Margheri, M ;
Barbagallo, R ;
Tamburino, C ;
Remigi, E ;
Briguori, C ;
Iakovou, I ;
Agostoni, P ;
Tsagalou, E ;
Melzi, G ;
Michev, I ;
Airoldi, F ;
Montorfano, M ;
Carlino, M ;
Colombo, A .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (12) :1466-1468
[4]   Preserved endothelial vasomotion and fibrinolytic function in patients with acute stent thrombosis or in-stent restenosis [J].
Chia, S ;
Megson, IL ;
Ludlam, CA ;
Fox, KA ;
Newby, DE .
THROMBOSIS RESEARCH, 2003, 111 (06) :343-349
[5]   Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents [J].
Chieffo, A ;
Bonizzoni, E ;
Orlic, D ;
Stankovic, G ;
Rogacka, R ;
Airoldi, F ;
Mikhail, GW ;
Montorfano, M ;
Michev, I ;
Carlino, M ;
Colombo, A .
CIRCULATION, 2004, 109 (22) :2732-2736
[6]   Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions [J].
Colombo, A ;
Drzewiecki, J ;
Banning, A ;
Grube, E ;
Hauptmann, K ;
Silber, S ;
Dudek, D ;
Fort, S ;
Schiele, F ;
Zmudka, K ;
Guagliumi, G ;
Russell, ME .
CIRCULATION, 2003, 108 (07) :788-794
[7]   Stent thrombosis: Historical perspectives and current trends [J].
Cutlip, DE .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2000, 10 (01) :89-101
[8]   Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab [J].
Furman, MI ;
Kereiakes, DJ ;
Krueger, LA ;
Mueller, MN ;
Pieper, K ;
Broderick, TM ;
Schneider, JF ;
Howard, WL ;
Fox, ML ;
Barnard, MR ;
Frelinger, AL ;
Michelson, AD .
AMERICAN HEART JOURNAL, 2001, 142 (05) :790-798
[9]   Atherothrombosis and high-risk plaque Part I: Evolving concepts [J].
Fuster, V ;
Moreno, PR ;
Fayad, ZA ;
Corti, R ;
Badimon, JJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (06) :937-954
[10]   Platelet activation and coronary stent implantation - Effect of antithrombotic therapy [J].
Gawaz, M ;
Neumann, FJ ;
Ott, I ;
May, A ;
Schomig, A .
CIRCULATION, 1996, 94 (03) :279-285